173 related articles for article (PubMed ID: 30779342)
1. miR-193: A new weapon against cancer.
Khordadmehr M; Shahbazi R; Sadreddini S; Baradaran B
J Cell Physiol; 2019 Aug; 234(10):16861-16872. PubMed ID: 30779342
[TBL] [Abstract][Full Text] [Related]
2. MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.
Chou NH; Lo YH; Wang KC; Kang CH; Tsai CY; Tsai KW
Anticancer Res; 2018 Jun; 38(6):3309-3318. PubMed ID: 29848678
[TBL] [Abstract][Full Text] [Related]
3. Biological Function of MicroRNA193a-3p in Health and Disease.
Grossi I; Salvi A; Abeni E; Marchina E; De Petro G
Int J Genomics; 2017; 2017():5913195. PubMed ID: 29038785
[TBL] [Abstract][Full Text] [Related]
4. Methylation-associated silencing of
Chen K; Liu MX; Mak CS; Yung MM; Leung TH; Xu D; Ngu SF; Chan KK; Yang H; Ngan HY; Chan DW
Theranostics; 2018; 8(2):423-436. PubMed ID: 29290818
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
6. Regulation of PLK1 through competition between hnRNPK, miR-149-3p and miR-193b-5p.
Shin CH; Lee H; Kim HR; Choi KH; Joung JG; Kim HH
Cell Death Differ; 2017 Nov; 24(11):1861-1871. PubMed ID: 28708135
[TBL] [Abstract][Full Text] [Related]
7. miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression.
Mansoori B; Mohammadi A; Ghasabi M; Shirjang S; Dehghan R; Montazeri V; Holmskov U; Kazemi T; Duijf P; Gjerstorff M; Baradaran B
J Cell Physiol; 2019 Jun; 234(6):9816-9825. PubMed ID: 30480817
[TBL] [Abstract][Full Text] [Related]
8. miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis-Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD.
Pekow J; Meckel K; Dougherty U; Huang Y; Chen X; Almoghrabi A; Mustafi R; Ayaloglu-Butun F; Deng Z; Haider HI; Hart J; Rubin DT; Kwon JH; Bissonnette M
Clin Cancer Res; 2017 Sep; 23(17):5281-5291. PubMed ID: 28600480
[No Abstract] [Full Text] [Related]
9. MiR-193a-3p functions as a tumour suppressor in human aldosterone-producing adrenocortical adenoma by down-regulating CYP11B2.
Zhang G; Zou X; Liu Q; Xie T; Huang R; Kang H; Lai C; Zhu J
Int J Exp Pathol; 2018 Apr; 99(2):77-86. PubMed ID: 29665181
[TBL] [Abstract][Full Text] [Related]
10. Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors.
Tahiri A; Leivonen SK; Lüders T; Steinfeld I; Ragle Aure M; Geisler J; Mäkelä R; Nord S; Riis ML; Yakhini Z; Kleivi Sahlberg K; Børresen-Dale AL; Perälä M; Bukholm IR; Kristensen VN
Carcinogenesis; 2014 Jan; 35(1):76-85. PubMed ID: 24104550
[TBL] [Abstract][Full Text] [Related]
11. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
[TBL] [Abstract][Full Text] [Related]
12. Deregulated MicroRNAs in Cancer-Associated Fibroblasts from Front Tumor Tissues of Lung Adenocarcinoma as Potential Predictors of Tumor Promotion.
Negrete-Garcia MC; Ramírez-Rodriguez SL; Rangel-Escareño C; Muñoz-Montero S; Kelly-García J; Vázquez-Manríquez ME; Santillán P; Ramírez MM; Ramírez-Martínez G; Ramírez-Venegas A; Ortiz-Quintero B
Tohoku J Exp Med; 2018 Oct; 246(2):107-120. PubMed ID: 30369556
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.
Jia L; Gui B; Zheng D; Decker KF; Tinay I; Tan M; Wang X; Kibel AS
Prostate; 2017 Jun; 77(9):1000-1011. PubMed ID: 28422308
[TBL] [Abstract][Full Text] [Related]
14. Interplay between MAPK/ERK signaling pathway and MicroRNAs: A crucial mechanism regulating cancer cell metabolism and tumor progression.
Asl ER; Amini M; Najafi S; Mansoori B; Mokhtarzadeh A; Mohammadi A; Lotfinejad P; Bagheri M; Shirjang S; Lotfi Z; Rasmi Y; Baradaran B
Life Sci; 2021 Aug; 278():119499. PubMed ID: 33865878
[TBL] [Abstract][Full Text] [Related]
15. MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR, respectively.
Pu Y; Zhao F; Cai W; Meng X; Li Y; Cai S
Clin Exp Metastasis; 2016 Apr; 33(4):359-72. PubMed ID: 26913720
[TBL] [Abstract][Full Text] [Related]
16. Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.
Mataki H; Seki N; Mizuno K; Nohata N; Kamikawaji K; Kumamoto T; Koshizuka K; Goto Y; Inoue H
Oncotarget; 2016 Nov; 7(44):72084-72098. PubMed ID: 27765924
[TBL] [Abstract][Full Text] [Related]
17. The highly expressed 5'isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration.
Salem O; Erdem N; Jung J; Münstermann E; Wörner A; Wilhelm H; Wiemann S; Körner C
BMC Genomics; 2016 Aug; 17():566. PubMed ID: 27502506
[TBL] [Abstract][Full Text] [Related]
18. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.
Chen J; Gao S; Wang C; Wang Z; Zhang H; Huang K; Zhou B; Li H; Yu Z; Wu J; Chen C
J Exp Clin Cancer Res; 2016 Nov; 35(1):173. PubMed ID: 27821145
[TBL] [Abstract][Full Text] [Related]
19. MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells.
Lin SR; Yeh HC; Wang WJ; Ke HL; Lin HH; Hsu WC; Chao SY; Hour TC; Wu WJ; Pu YS; Huang AM
J Cell Biochem; 2017 Jun; 118(6):1563-1573. PubMed ID: 27918099
[TBL] [Abstract][Full Text] [Related]
20. Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness.
Matsushita R; Yoshino H; Enokida H; Goto Y; Miyamoto K; Yonemori M; Inoguchi S; Nakagawa M; Seki N
Oncotarget; 2016 May; 7(19):28460-87. PubMed ID: 27072587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]